| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 8.8e-05 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -6.2e-05 | 1 |